Cesarean Delivery Completed Phase 4 Trials for Ropivacaine (DB00296)

IndicationStatusPhase
DBCOND0036001 (Cesarean Delivery)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01170702Transverse Abdominis Plane (TAP) Block After Cesarean DeliveryTreatment